BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vorstenbosch S, Te Winkel B, van Gelder MMHJ, Kant A, Roeleveld N, van Puijenbroek E. Aim and Design of pREGnant, the Dutch Pregnancy Drug Register. Drug Saf 2019;42:1-12. [PMID: 30246225 DOI: 10.1007/s40264-018-0722-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Sillis L, Foulon V, Verbakel JY, Ceulemans M. Experiences and Perspectives of Marketing Authorisation Holders towards Medication Safety Monitoring during Pregnancy: A Pan-European Qualitative Analysis. IJERPH 2022;19:4248. [DOI: 10.3390/ijerph19074248] [Reference Citation Analysis]
2 van Gelder MMHJ, Rog A, Bredie SJH, Kievit W, Nordeng H, van de Belt TH. Social media monitoring on the perceived safety of medication use during pregnancy: A case study from the Netherlands. Br J Clin Pharmacol 2019;85:2580-90. [PMID: 31378978 DOI: 10.1111/bcp.14083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
3 Houben E, Te Winkel B, Steegers EAP, Herings RMC. Dutch trends in the use of potentially harmful medication during pregnancy. Br J Clin Pharmacol 2020;86:2377-92. [PMID: 32374086 DOI: 10.1111/bcp.14341] [Cited by in F6Publishing: 2] [Reference Citation Analysis]